Discover how REAC therapy accelerates post-stroke recovery. Clinical data shows this non-invasive treatment improves motor function and autonomy in less time.

Stroke is a leading cause of long-term disability worldwide. The period immediately following the acute event, known as the “subacute” phase, is a critical window where the brain’s neuroplasticity is maximized, offering the greatest opportunity for functional recovery. Despite advances in conventional rehabilitation therapies, many patients do not achieve a full recovery, highlighting the need for complementary strategies that can act on central motor control mechanisms from the earliest stages.
In this context, REAC (Radio Electric Asymmetric Conveyer) technology emerges as an innovative, non-invasive approach. This article, based on the findings of a clinical study published in Cureus, explores how specific REAC neurobiological modulation protocols—namely Neuro Postural Optimization (NPO) and Neuro Muscular Optimization (NMO)—can significantly accelerate and enhance the outcomes of post-stroke rehabilitation.
The key points we will analyze include:
REAC technology utilizes very low-intensity, asymmetrically conveyed radioelectric fields to interact with the body’s endogenous bioelectric currents. The NPO and NMO protocols are specifically designed to act on the dysfunctional adaptive processes that occur after neurological damage.
The primary goal of integrating REAC treatments into early post-stroke rehabilitation is to enhance functional recovery by acting upstream—that is, on the central control circuits rather than solely on peripheral mechanisms.
The mechanism of action is based on endogenous bioelectric modulation. Unlike other neuromodulation techniques that impose an external stimulus, REAC technology acts only where dysregulations exist, helping the system regain its intrinsic capacity for self-correction. This process promotes:
The synergistic integration of NPO and NMO allows for a rapid and stable effect. NPO initiates the change, while NMO consolidates it, guiding the patient toward a more robust motor recovery and autonomy.
The clinical study compared a group of 13 patients treated with standard rehabilitation integrated with REAC protocols (NPO and NMO) against a historical control group of 13 patients who received only standard rehabilitation. The results were remarkable.
The REAC-treated group showed significantly greater improvements:
Most significantly, these superior outcomes were achieved despite a shorter average length of hospital stay (30.8 days for the REAC group versus 34.4 days for the control group). This suggests that integrating REAC technology not only improves the final outcome but also accelerates the recovery process.
This data is supported by other research. For instance, a study using functional magnetic resonance imaging (fMRI) demonstrated that a single REAC pulse induces lasting changes in brain activation. Furthermore, the efficacy of REAC protocols in improving motor function has also been observed in other neurological conditions, such as post-polio syndrome and Parkinson’s disease, reinforcing the hypothesis of a central, network-level mechanism of action.
The study convincingly demonstrates the potential role of REAC neurobiological modulation, through the NPO and NMO protocols, in enhancing early functional recovery in post-stroke patients. The observed improvements in motor performance and autonomy, coupled with the rapid and stable resolution of functional dysmetria, suggest that REAC treatments act by facilitating neurofunctional reorganization and optimizing motor control circuits.
The comparative analysis with a control group reinforces the clinical relevance of these findings, particularly considering the superior recovery achieved in a shorter timeframe. This evidence supports the use of REAC neuromodulation protocols as effective and safe adjunctive tools to be integrated into comprehensive post-stroke rehabilitation pathways.
To learn more about the potential of REAC technology and discuss its integration into rehabilitation pathways, we invite you to contact our specialists for more information and scientific documentation.
Don’t miss out on the full article. Click here to continue reading!
Dr. Vania Fontani MD, PhD, is a prominent figure in the field of regenerative medicine and neurobiological modulation.
She has dedicated her career to research and the development of innovative technologies for human well-being.
Currently, Dr. Fontani holds the position of Scientific Director at the Rinaldi Fontani Institute in Florence, where she leads the Department of Regenerative Medicine.
In collaboration with Prof. Salvatore Rinaldi, she co-developed the REAC® (Radio Electric Asymmetric Conveyer) technology, a non-invasive methodology aimed at modulating endogenous bioelectric activity to promote health and well-being.
Her research work is documented in over 60 scientific publications, with a significant impact in the field of neuromodulation and regenerative medicine.
Her experience and expertise make her an ideal speaker for international events focused on innovation and longevity
Learn more:
• Publications: PubMed – Rinaldi S, Fontani V
Physician and researcher, pioneer in neurobiological modulation, regenerative medicine, and anti-senescence therapies Scientific Director – Rinaldi Fontani Institute, Florence, Italy
ORCID: 0000-0002-8961-6316
Profile and Mission
Salvatore Rinaldi is an internationally recognized innovator for his groundbreaking
contribution to the study and clinical application of neurobiological modulation using
asymmetrically conveyed radio-electric signals (REAC). His work has redefined the
boundaries of regenerative medicine and longevity, demonstrating how optimizing
endogenous bioelectrical activity can promote cellular reprogramming, recovery of
compromised functions, and the prevention of age-related decline.
Research Milestones
Rinaldi’s research has opened new frontiers in the understanding and treatment of
neurodegenerative diseases and cellular aging processes. Among his most significant
contributions:
Regenerative Medicine:
Anti-Senescence and Longevity:
Neurodegenerative Diseases – Efficacy of REAC Technology in Alzheimer’s and
Neurodegeneration Models:
Scientific Vision
Salvatore Rinaldi’s work demonstrates that bioelectrical modulation is not merely a
theoretical concept, but a concrete and reproducible therapeutic strategy to counteract
aging, support cellular repair processes, and prevent tissue degeneration.
Learn more:
• ORCID Profile: 0000-0002-8961-6316
• Publications: PubMed – Rinaldi S, Fontani V